Trimbow triple combination therapy approve for use in EU for asthma

Trimbow (beclometasone/formoterol/glycopyrronium) has been approved for maintenance treatment of adult asthma patients, whose condition is not adequately controlled with a combination of long-acting beta2-agonist and medium dose of inhaled corticosteroid.

PharmaTimes